ZURICH, Nov 11 (Reuters) - Switzerland increased funds it
has set aide to buy vaccines against COVID-19 to 400 million
Swiss francs ($436 million), from 300 million francs previously,
saying on Wednesday the additional infusion is necessary to
ensure it can get supplies it needs.
Switzerland has already reserved nearly 10 million doses of
prospective vaccines from Moderna and AstraZeneca
that are now in late-stage trials. It is also in talks
with additional manufacturers as it hopes to give first shots
against the new coronavirus in the first half of 2021, should
one be approved by national regulators.
($1 = 0.9171 Swiss francs)
(Reporting by John Miller and Silke Koltrowitz, editing by
Michael Shields)